Toosonix A/S has launched two trials as it moves to gather data enabling its high-intensity focused ultrasound (HIFU) device to get approval for use in clinical dermatology indications. The company ...
Nasdaq: Castle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology ...
Castle Biosciences to Share Data Reinforcing the Clinical Value of Its Dermatologic Portfolio of Gene Expression Profile Tests at the 22nd Annual Winter Clinical Dermatology ...
Business Wire: New Data Highlights Clinical Utility and Performance of Castle Biosciences’ Dermatologic Test Portfolio at the 2023 Fall Clinical Dermatology Conference®
Castle will share new data across its dermatologic portfolio of gene expression profile (GEP) tests at the 2023 Fall Clinical Dermatology Conference®.
New Data Highlights Clinical Utility and Performance of Castle Biosciences’ Dermatologic Test Portfolio at the 2023 Fall Clinical Dermatology Conference®
European Medical Journal: Ultrasound and CT Improve Nodal Staging in High-Risk cSCC
Ultrasound and CT improve nodal staging in high-risk cSCC but show reduced accuracy in immunosuppressed patients. Learn more about diagnostic strategies.
High-frequency ultrasound (HFUS) has emerged as a valuable non-invasive imaging modality in dermatology, offering detailed visualisation of the skin’s layers and its pathologies. Its high resolution ...
February 19-22 event in Sarasota, Florida features hands-on ultrasound training and sessions on emerging biologics, imaging, and diagnostic dermatology. MALVERN, PA ...
CHICAGO — If a dermatoscope is a third eye for dermatologists, ultrasound (US) “will become your fourth eye,” dermatologist and Mohs surgeon Jane Yoo, MD, MPP, said at the American Society for ...